Cellectar Biosciences, Inc.
CLRB
$2.37
-$0.05-1.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 307.26% | -36.75% | 5.11% | 13.71% | -20.60% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.95% | 9.21% | -21.08% | -32.30% | 59.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 276.36% | -33.99% | 3.06% | 7.96% | -15.28% |
|
|
|||||
| Total Current Assets | 276.36% | -33.99% | 3.06% | 7.96% | -15.28% |
| Net Property, Plant & Equipment | -4.66% | 100.30% | -6.76% | -6.84% | -6.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.81% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 229.49% | -25.76% | 2.40% | 6.81% | -14.63% |
|
|
|||||
| Total Accounts Payable | 10.45% | 228.00% | -64.12% | -14.19% | 20.76% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 4.38% | 4.35% | 4.43% |
| Total Finance Division Other Current Liabilities | -88.59% | -79.45% | -9.57% | -26.85% | -46.75% |
| Total Other Current Liabilities | -88.59% | -79.45% | -9.57% | -26.85% | -46.75% |
| Total Current Liabilities | 7.47% | 2.61% | -3.31% | -16.27% | -2.56% |
|
|
|||||
| Total Current Liabilities | 7.47% | 2.61% | -3.31% | -16.27% | -2.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.05% | 394.12% | -7.89% | -7.08% | -6.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.69% | 26.56% | -3.60% | -15.73% | -2.79% |
|
|
|||||
| Common Stock & APIC | 12.24% | 0.16% | 2.15% | 2.40% | 1.25% |
| Retained Earnings | -2.52% | -2.10% | -2.01% | -1.71% | -2.15% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 961.43% | -64.89% | 7.22% | 34.37% | -28.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 961.43% | -64.89% | 7.22% | 34.37% | -28.04% |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 533.27% | -52.44% | 5.76% | 25.61% | -22.50% |
|
|
|||||